Korean Journal of Psychosomatic Medicine (정신신체의학)

Korean Psychosomatic Society (한국정신신체의학회)
권호 표지
DOI QR코드

DOI QR Code

Association of Hemoglobin Levels and Cognitive Function in Alzheimer's Disease and Mild Cognitive Impairment

알츠하이머병과 경도인지장애에서 헤모글로빈 농도와 인지기능과의 연관성

  • Park, Joon Kyung (Department of Psychiatry, Ilsan Paik Hospital, Inje University College of Medicine) ;
  • Lee, Kang Joon (Department of Psychiatry, Ilsan Paik Hospital, Inje University College of Medicine) ;
  • Kim, Hyun (Department of Psychiatry, Ilsan Paik Hospital, Inje University College of Medicine)
  • 박준경 (인제대학교 의과대학 일산백병원 정신건강의학교실) ;
  • 이강준 (인제대학교 의과대학 일산백병원 정신건강의학교실) ;
  • 김현 (인제대학교 의과대학 일산백병원 정신건강의학교실)
  • Received : 2016.04.20
  • Accepted : 2016.06.15
  • Published : 2016.06.30
Download PDF
⟨ Previous Next ⟩

Abstract

Objectives : Anemia is a common problem in the management of elderly patients. Recent studies reported that anemia was associated with cognitive impairment and Alzheimer's disease. This study was aimed to analyze the differences of hemoglobin levels in Korean patients with Alzheimer's disease(AD) dementia, mild cognitive impairment(MCI), and healthy controls. Furthermore, the study also examined if any association between hemoglobin levels and cognitive functions existed. Methods : A total of 116 Korean elderly adults were participated in this study(mean age 74.67 years ; 60.3% female). The Korean version of the Mini-Mental State Examination(MMSE-K), Clinical Dementia Rating(CDR) and Global Deterioration Scale(GDS) were applied to all subjects. Hematological and related blood chemistry values were investigated. Results : We found that patients with AD dementia had significantly lower hemoglobin and hematocrit levels than MCI subjects and healthy control group. The hemoglobin levels showed a positive correlation with MMSE-K and negative correlation with CDR, GDS. Conclusions : Among Korean elderly, low hemoglobin level is associated with a cognitive impairment. This study indicates that AD is associated with anemia, and low hemoglobin levels may contribute to potentially useful clinical markers of AD. The risk factor for dementia needs to be confirmed by prospective longitudinal studies in a larger group of patients.

연구목적 본빈혈은 노인 환자들에서 흔한 내과적 문제이다. 최근 연구는 빈혈이 인지기능 저하 및 알츠하이머병 치매와 연관성이 있다고 보고되고 있다. 본 연구는 한국 노인들에서 헤모글로빈 농도와 알츠하이머병 치매 및 경도 인지기능 장애와의 연관성에 대해 연구하기 위해 실시되었다. 방 법 116명의 대상자들이 본 연구에 참여하였다(평균 연령 : 74.67세, 여성 : 60.3%). 한국판 간이정신상태검사(MMSE-K), 임상치매평가척도(CDR), 전반적 퇴화척도(GDS)를 사용하여 대상자들을 평가하였고, 혈액학적 검사를 실시하였다. 결 과 알츠하이머병 치매 환자들이 경도인지장애군과 정상군에 비해서 유의미하게 낮은 헤모글로빈 농도와 적혈구 용적율을 가진다는 것이 관찰되었다. 헤모글로빈 농도는 MMSE-K와 양의 상관관계를 나타내었으며, overall CDR 및 GDS와는 음의 상관관계를 보였다. 결 론 한국 노인들에서 낮은 헤모글로빈 농도는 인지기능손상과 연관이 있는 것으로 나타났다. 본 연구 결과 알츠하이머병 치매는 빈혈과 연관이 있었으며, 이를 통해 낮은 헤모글로빈 농도가 알츠하이머병의 유용한 임상적 표지자로서 의미를 가지고 있다고 생각해 볼 수 있겠다. 치매에 대한 위험 요소는 더 광범위한 환자 군에서 전향적 종단 연구에 의해 확인하는 것이 필요하겠다.

Keywords

References

  1. Hampel H, Prvulovic D, Teipel S, Jessen F, Luckhaus C, Frolich L, Matthias WR, Dodel R, Leyhe T, Bertram L, Hoffmann W, Faltraco F. The future of Alzheimer's disease: The next 10 years, Review Article. Progress in Neurobiology 2011;95:718-728. https://doi.org/10.1016/j.pneurobio.2011.11.008
  2. Prince M, Jackson J. World Alzheimer report 2009. London: Alzheimer's disease International;2009. p.38.
  3. Alzheimer's Association. 2013 Alzheimer's disease facts and figures. Alzheimers Dement 2013;9:208-245. https://doi.org/10.1016/j.jalz.2013.02.003
  4. Rensbergen GV, Nawrot T. Medical conditions of nursing home admissions. BMC Geriatr 2010;10:46. https://doi.org/10.1186/1471-2318-10-46
  5. Zakai NA, Katz R, Hirsch C, Shlipak MG, Chaves PH, Newman AB, Cushman M. A prospective study of anemia status, hemoglobin concentration, and mortality in an elderly cohort: the Cardiovascular Health Study. Arch Intern Med 2005;165:2214-2220. https://doi.org/10.1001/archinte.165.19.2214
  6. Chaves PH, Carlson MC, Ferrucci L, Guralnik JM, Serba R, Fried LP. Association between mild anemia and executive function impairment in community-dwelling older women: The Women's Health and Aging Study II. J Am Geriatr Soc 2006;54:1429-1435. https://doi.org/10.1111/j.1532-5415.2006.00863.x
  7. World Health Organization. Nutritional anemia: report of a WHO Scientific Group. World Health Organ Tech Rep Ser 1968;405:5-37.
  8. National Center for Health Statistics. Plan and operation of the Third National Health and Nutrition Examination Survey, 1988-94. Vital Health Stat 1.1994;32:1-407.
  9. Ferrer I, Gomez A, Carmona M, Huesa G, Porta S, Riera-Codina M, Gustincich S, Aso E. Neuronal hemoglobin is reduced in Alzheimer's disease, Argyrophilic Grain disease, Parkinson's disease, and dementia with Lewy bodies. J Alzheimers Dis 2011;23:537-550. https://doi.org/10.3233/JAD-2010-101485
  10. Smith MA, Harris PL, Sayre LM, Perry G. Iron accumulation in Alzheimer disease is a source of redox-generated free radicals. Proc Natl Acad Sci USA 1997;94:9866-9868. https://doi.org/10.1073/pnas.94.18.9866
  11. Beard CM, Kokmen E, O'Brien PC, Ania BJ, Melton LJ 3rd. Risk of Alzheimer's disease among elderly patients with anemia: population -based investigations in Olmsted Country, Minnesota. Ann Epidemiol 1997;7:219-224. https://doi.org/10.1016/S1047-2797(97)00015-X
  12. Milward EA, Grayson DA, Creasey H, Janu MR, Brooks WS, Broe GA. Evidence for association of anemia with vascular dementia. Neurorepor 1999;10:2377-2381. https://doi.org/10.1097/00001756-199908020-00029
  13. Shah RC, Wilson RS, Tang Y, Dong X, Murray A, Bennett DA. Relation of hemoglobin to level of cognitive function in older persons. Neuroepidemiology 2009;32:40-46. https://doi.org/10.1159/000170905
  14. Pandav RS, Chandra V, Dodge HH, DeKosky ST, Ganguli M. Hemoglobin Levels and Alzheimer Disease: An Epidemiologic Study in India. AM J Geriatr Psyhicatry 2004;12:523-526. https://doi.org/10.1097/00019442-200409000-00011
  15. Deal JA, Carlson MC, Xue QL, Fried LP, Chaves PH. Anemia and 9-year domain-specific cognitive decline in community-dwelling older women: the Women's Health and Aging Study II. J Am Geriatr Soc 2009;57:1604-1611. https://doi.org/10.1111/j.1532-5415.2009.02400.x
  16. Peters R, Burch L, Warner J, Beckett N, Poulter R, Bulpitt C. Hemoglobin, anemia, dementia and cognitive decline in the elderly, a systematic review. BMC Geriatr 2008;8:18. https://doi.org/10.1186/1471-2318-8-18
  17. Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol 1999;56:303-308. https://doi.org/10.1001/archneur.56.3.303
  18. Park JH, Kwon YC. Standardization of Korean Version of the Mini-Mental State Examination(MMSE-Kfor Use in the Elderly. J Clin Psyhicatry 2012;73;1548-1554.
  19. Morris JC. The Clinical Dementia Rating Scale(CDR): Current version and scoring rules. Neurology;1993.
  20. Reisberg B, Ferris SH, de Leon MJ, Crook T. Global Deterioration Scale(GDS). Psychopharmacol Bull 1988;24:661-663.
  21. Denny SD, Kuchibhatla MN, Cohen HJ. Impact of anemia on mortality, cognition, and function in community-dwelling elderly. Am J Med 2006;119:327-334. https://doi.org/10.1016/j.amjmed.2005.08.027
  22. Guralnik JM, Eisenstaedt RS, Ferrucci L, Klein HG, Woodman RC. Prevalence of anemia in persons 65 years and older in the United states; evidence for a high rate of unexplained anemia. Blood 2004;104:2263-2268. https://doi.org/10.1182/blood-2004-05-1812
  23. Argyriadou S, Vlachonikolis I, Melisopoulous H, Katachanakis K, Lionis C. In what extent anemia coexists with cognitive impairment in elderly: a cross sectional study in Greece. BMC Fam Pract 2001;2:5. https://doi.org/10.1186/1471-2296-2-5
  24. Beghe C, Wilson A, Ershler WB. Prevalence and outcomes of anemia in geriatrics: a systematic review of the literature. Am J Med 2004;116:3S-10S.
  25. Broe GA, Henderson AS, Creasey H, Mc Cusker E, Korten AE, Jorm AF, Longley W, Anthony JC. A case-control study of Alzheimer's disease in Australia. Neurology 1990;40: 1698-1707. https://doi.org/10.1212/WNL.40.11.1698
  26. Kokmen E, Beard CM, Chandra V, offord KP, Schoenverg BS, Ballard DJ. Clinical risk factors for Alzheimer's disease: A population-based case-control study. Neurology 1991;41: 1393-1397. https://doi.org/10.1212/WNL.41.9.1393
  27. Hong CH, Falvey C, Harris TB, Simonsick EM, Satterfield S, Ferrucci L, Metti AL, Patel KV, Yaffe K. Anemia and risk of dementia in older adults. Neurology 2013;81:528-533. https://doi.org/10.1212/WNL.0b013e31829e701d
  28. Faux NG, Rembach A, Wiley J, Ellis KA, Ames D, Fowler CJ, Martins RN, Pertile KK, Rumble RL, Trounson B, Masters CL, AIBL Research Group, Bush AI. An anemia of Alzheimer's disease. Mol Psychiatry 2014;19:1227-1234. https://doi.org/10.1038/mp.2013.178
  29. Shah RC, Buchman AS, Wilson RS, Leurgans SE, Bennett DA. Hemoglobin level in older persons and incident Alzheimer disease: prospective cohort analysis. Neurology 2011;77:219- 226. https://doi.org/10.1212/WNL.0b013e318225aaa9
  30. Gruppo Italiano Studio Policitemia. Polycythemia vera: the natural history of 1213 patients followed for 20 years. Ann Intern Med 1995;123:656-664. https://doi.org/10.7326/0003-4819-123-9-199511010-00003
  31. Salive ME, Cornoni-Huntley J, Guralink JM, Phillips CL, Wallace RB, Ostfeld AM, Cohen HJ. Anemia and hemoglobin levels in older persons: relationship with age, gender, and health status. J AM Geriatr Soc 1992;40:489-496. https://doi.org/10.1111/j.1532-5415.1992.tb02017.x
  32. Yavuz BB, Cankurtaran M, Haznedaroglu IC, Halil M, Ulger Z, Altun B, Ariogul s. Iron deficiency can cause cognitive impairment in geriatric patients. J Nutr Health Aging 2012; 16:220-224. https://doi.org/10.1007/s12603-011-0351-7
  33. Hall ED, Oostveen JA, Dunn E, Carter DB. Increased amyloid protein precursor and apolipoprotein E immunoreactivity in the selectively vulnerable hippocampus following transient forebrain ischemia in gerbils. Exp Neurol 1995;135:17-27. https://doi.org/10.1006/exnr.1995.1062
  34. Atti AR, Palmer K, Volpato s, Zuliani G, Winblad B, Fratiglioni L. Anemia increases the risk of dementia in cognitively intact elderly. Neurobiol Aging 2006;27:278-284. https://doi.org/10.1016/j.neurobiolaging.2005.02.007
  35. Debette S, Markus HS. The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysis. BMJ 2010;341:c3666. https://doi.org/10.1136/bmj.c3666
  36. Gomez-Isla T, Hollister R, West H, Mui S, Growdon JH, Petersen RC, Parisi JE, Hyman BT. Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease. Ann Neurol 1997;41:17-24. https://doi.org/10.1002/ana.410410106
  37. Assaraf MI, Diaz Z, Limberman A, Miller WH Jr, Arvanitakis Z, Li Y, Bennett DA, Schipper HM. Brain erythropoietin receptor expression in Alzheimer's disease and mild cognitive impairment. J Neuropathol Exp Neurol 2007;66:389-398. https://doi.org/10.1097/nen.0b013e3180517b28
  38. Maiese K, Li F, Chong ZZ. New avenues of exploration for erythropoietin. JAMA 2005;293:90-95. https://doi.org/10.1001/jama.293.1.90
  39. Song X, Mitnitski A, Rockwood K. Nontraditional risk factor combine to predict Alzheimer's disease and dementia. Neurology 2011;77:227-234. https://doi.org/10.1212/WNL.0b013e318225c6bc